Италия - италиански - AIFA (Agenzia Italiana del Farmaco)

menarini international operations luxembourg s.a. - olmesartan medoxomil, amlodipine and hydrochlorothiazide - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Италия - италиански - AIFA (Agenzia Italiana del Farmaco)

menarini international operations luxembourg s.a. - olmesartan medoxomil, amlodipine and hydrochlorothiazide - olmesartan medoxomil, amlodipine and hydrochlorothiazide

Европейски съюз - италиански - EMA (European Medicines Agency)

billev pharma aps - lutetium (177lu) chloride - imaging dei radionuclidi - radiofarmaci terapeutici - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Европейски съюз - италиански - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabete mellito, tipo 2 - farmaci usati nel diabete - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , triplice terapia di associazione) in aggiunta alla dieta e all'esercizio fisico in pazienti non adeguatamente controllati il loro dosaggio massimo tollerato di metformina ed una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Европейски съюз - италиански - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Италия - италиански - AIFA (Agenzia Italiana del Farmaco)

noridem enterprises ltd - colistina - colistina

Италия - италиански - AIFA (Agenzia Italiana del Farmaco)

becton dickinson france s.a.s. - clorexidina, associazioni - clorexidina, associazioni

Италия - италиански - Ministero della Salute

syngenta italia s.p.a. - s-metolachlor; - concentrato emulsionabile - 86.5 g i valori indicati sono per 100 g di prodotto. - diserbante

Италия - италиански - Ministero della Salute

syngenta italia s.p.a. - s-metolachlor; - concentrato emulsionabile - 86.5 g i valori indicati sono per 100 g di prodotto. - diserbante

Италия - италиански - Ministero della Salute

syngenta italia s.p.a. - s-metolachlor; mesotrione; - emulsione acqua in olio - 46.5 g; 5.58 g i valori indicati sono per 100 g di prodotto. - diserbante